Visceral heterotaxy

Visceral Heterotaxy: curated summary

2026-04-14
Manual MONDO:0018677 Model: n/a 12 citations

Visceral Heterotaxy: curated summary

Disease anchor

MONDO:0018677 with preferred label visceral heterotaxy is the strongest structured anchor for this entry. MONDO lists heterotaxy syndrome and situs ambiguus as exact synonyms, so the issue wording maps cleanly to this term. The broader literature also uses atrial isomerism and atrial appendage isomerism, but those labels function better as spectrum descriptors than as the primary disease anchor because MONDO support for left-versus-right isomerism is not symmetric at the active disease level.

Mechanistic summary

  1. Heterotaxy is a left-right axis disorder rooted in early embryonic symmetry-breaking failure. The most stable disease-mechanism statement from primary literature is that motile cilia at the left-right organizer are upstream of conserved laterality signaling.
  2. The nodal-PITX2 cascade is the clearest ontology-groundable downstream mechanism. It connects the organizer defect to abnormal cardiac and visceral situs patterning.
  3. Human genetics is markedly heterogeneous rather than gene-specific at the disease level. Reviews and exome cohorts support a mixed architecture spanning transcription factors, signaling genes, and ciliary genes, with representative monogenic causes including ZIC3, GDF1, DAND5, DNAH5, and PKD1L1.

Clinical and management summary

  1. The spectrum is classically divided into right atrial isomerism and left atrial isomerism. Cardiac disease dominates morbidity, with atrioventricular septal defects especially common.
  2. Important extracardiac disease includes intestinal malrotation and splenic dysfunction. Heart block is particularly associated with left atrial isomerism in fetal cohorts.
  3. Treatment is anatomy-driven rather than disease-specific pharmacotherapy. The most defensible disease-level actions are congenital heart surgery (univentricular palliation or biventricular repair depending on anatomy) plus infection-prevention care for patients with asplenia or hyposplenism (vaccination and antibiotic prophylaxis).

References